Otsuka Pharmaceutical Netherlands B.V.

Spain

All drugs from this manufacturer

  • ABILIFY 1 MG/ML ORAL SOLUTION

    It is used to treat adults and adolescents aged 15 years or older with symptoms such as hearing or seeing things that do not exist, distrust, false beliefs, incoherent speech, and emotional monotony. It is also used in adults and adolescents aged 13 years or older to treat symptoms of euphoria, excessive energy, a decreased need for sleep, rapid speech, and severe irritability.

    Dosage form: solution, oral

    Active substance Dosage
    aripiprazole 1 mg

    ATC: N05A N05AX N05AX12

  • It is used in adults and adolescents to treat illnesses with symptoms such as hearing, seeing, or feeling things that do not exist, distrust, false beliefs, incoherent speech, and emotional monotony. It is also used to treat symptoms of euphoria, excessive energy, the need to sleep much less than usual, and irritability in adults and adolescents aged 13 years or older.

    Dosage form: tablets, buccodispersable

    Active substance Dosage
    aripiprazole 10 mg

    ATC: N05A N05AX N05AX12

  • It is used in adults and adolescents aged 15 years and older to treat conditions with symptoms such as hearing, seeing, or feeling things that do not exist, distrust, false beliefs, incoherent speech, and emotional flatness. It is also used in adults and adolescents aged 13 years and older to treat disorders characterized by euphoria, exaggerated energy, reduced need for sleep, rapid speech, or severe irritability.

    Dosage form: tablets

    Active substance Dosage
    aripiprazole 10 mg

    ATC: N05A N05AX N05AX12

  • It is used in adults and adolescents to treat illnesses with symptoms such as hearing, seeing, or feeling things that do not exist, distrust, false beliefs, incoherent speech, and emotional monotony. It is also used to treat disorders characterized by euphoria, exaggerated energy, the need to sleep much less than usual, and severe irritability.

    Dosage form: tablets, buccodispersable

    Active substance Dosage
    aripiprazole 15 mg

    ATC: N05A N05AX N05AX12

  • It is used in adults and adolescents aged 15 years or older to treat illnesses with symptoms such as distrust, false beliefs, incoherent speech, or sensing things that do not exist. It is also used in adults and adolescents aged 13 years or older to treat disorders with symptoms of euphoria, excessive energy, or severe irritability.

    Dosage form: tablets

    Active substance Dosage
    aripiprazole 15 mg

    ATC: N05A N05AX N05AX12

  • It is used in adults and adolescents aged 15 years or older to treat illnesses with symptoms such as hearing or seeing things that do not exist, distrust, false beliefs, incoherent speech, and emotional monotony. It is also used in adults and adolescents aged 13 years or older to treat disorders with symptoms of euphoria, exaggerated energy, decreased need for sleep, rapid speech, or severe irritability.

    Dosage form: tablets

    Active substance Dosage
    aripiprazole 30 mg

    ATC: N05A N05AX N05AX12

  • It is used in adults and adolescents aged 15 years or older to treat illnesses with symptoms such as distrust, false beliefs, incoherent speech, or sensing things that do not exist. It is also used in adults and adolescents aged 13 years or older to treat disorders with symptoms of euphoria, excessive energy, or severe irritability.

    Dosage form: tablets

    Active substance Dosage
    aripiprazole 5 mg

    ATC: N05A N05AX N05AX12

  • It is used to rapidly treat symptoms of agitation and behavioral disturbances (such as distrust, false beliefs, incoherent speech, or exaggerated euphoria) in people with certain mental illnesses, when oral treatment is not appropriate.

    Dosage form: solution for injection

    Active substance Dosage
    aripiprazole 7,5 mg

    ATC: N05A N05AX N05AX12

  • It is used to treat schizophrenia in adult patients who are already sufficiently stabilized with oral aripiprazole treatment.

    Dosage form: suspension for injection, prolonged release

    Active substance Dosage
    aripiprazole 300 mg

    ATC: N05A N05AX N05AX12

  • It is used to treat schizophrenia in adult patients who are already sufficiently stabilized with oral aripiprazole treatment.

    Dosage form: suspension for injection, prolonged release

    Active substance Dosage
    aripiprazole 400 mg

    ATC: N05A N05AX N05AX12

  • It is used to treat schizophrenia in adult patients who are already sufficiently stabilized with aripiprazole treatment. It helps relieve the symptoms of the disease and reduce the risk of relapse.

    Dosage form: suspension for injection, prolonged release, in pre-filled syringe

    Active substance Dosage
    aripiprazole monohydrate 748,8 mg

    ATC: N05A N05AX N05AX12

  • It is used to treat schizophrenia in adults who are already sufficiently stabilized with aripiprazole treatment. It helps relieve the symptoms of the disease and reduce the risk of relapse.

    Dosage form: suspension for injection, prolonged release, in pre-filled syringe

    Active substance Dosage
    aripiprazole monohydrate 998,4 mg

    ATC: N05A N05AX N05AX12

  • It is used to treat acute myeloid leukemia (AML) in adults when chemotherapy is not considered appropriate.

    Dosage form: tablets, film-coated

    Active substance Dosage
    decitabine 35 mg
    cedazuridine 100 mg

    ATC: L01B L01BC L01BC58

  • It is used to treat autosomal dominant polycystic kidney disease (ADPKD) in adults with chronic kidney disease (stages 1 to 4) who show rapid disease progression. It helps slow the growth of cysts in the kidneys, reduces symptoms, and increases urine production.

    Dosage form: tablets

    Active substance Dosage
    tolvaptan 45 mg
    tolvaptan 15 mg

    ATC: C03X C03XA C03XA01

  • It is used to treat autosomal dominant polycystic kidney disease (ADPKD) in adults with chronic kidney disease (stages 1 to 4) who show signs of rapid disease progression. It helps slow the growth of cysts in the kidneys, reduces symptoms, and increases urine production.

    Dosage form: tablets

    Active substance Dosage
    tolvaptan 15 mg

    ATC: C03X C03XA C03XA01

  • It is used to treat autosomal dominant polycystic kidney disease (ADPKD) in adults with chronic kidney disease (stages 1 to 4) who show rapid disease progression. It helps slow the growth of cysts in the kidneys, reduces symptoms, and increases urine production.

    Dosage form: tablets

    Active substance Dosage
    tolvaptan 60 mg
    tolvaptan 30 mg

    ATC: C03X C03XA C03XA01

  • It is used to treat autosomal dominant polycystic kidney disease (ADPKD) in adults with chronic kidney disease (stages 1 to 4) who show signs of rapid disease progression. It helps slow the growth of kidney cysts, reduces symptoms, and increases urine production.

    Dosage form: tablets

    Active substance Dosage
    tolvaptan 90 mg
    tolvaptan 30 mg

    ATC: C03X C03XA C03XA01

  • It is used to treat autosomal dominant polycystic kidney disease (ADPKD) in adults with chronic kidney disease (stage 1 to 4) who show signs of rapidly progressing disease. It helps slow the development of kidney cysts, reduces symptoms, and increases urine production.

    Dosage form: tablets

    Active substance Dosage
    tolvaptan 30 mg

    ATC: C03X C03XA C03XA01

  • It is used to treat lupus nephritis (kidney inflammation caused by lupus) in adults aged 18 years and older.

    Dosage form: capsules, soft gelatin

    Active substance Dosage
    voclosporin 7,9 mg

    ATC: L04A L04AD L04AD03

  • It is used to treat schizophrenia in adults and adolescents aged 13 years or older. It can help control symptoms and prevent relapses.

    Dosage form: tablets, film-coated

    Active substance Dosage
    brexpiprazol 0,5 mg

    ATC: N05A N05AX N05AX16

  • It is used to treat schizophrenia in adults and adolescents aged 13 years or older. It can help control symptoms and prevent relapses.

    Dosage form: tablets, film-coated

    Active substance Dosage
    brexpiprazol 1 mg

    ATC: N05A N05AX N05AX16

  • It is used to treat schizophrenia in adults and adolescents aged 13 years or older. It can help control symptoms and prevent relapses.

    Dosage form: tablets, film-coated

    Active substance Dosage
    brexpiprazol 2 mg

    ATC: N05A N05AX N05AX16

  • It is used to treat schizophrenia in adults and adolescents aged 13 years or older. It can help control symptoms and prevent relapses.

    Dosage form: tablets, film-coated

    Active substance Dosage
    brexpiprazol 3 mg

    ATC: N05A N05AX N05AX16

  • It is used to treat schizophrenia in adults and adolescents aged 13 years or older. It can help control symptoms and prevent relapses.

    Dosage form: tablets, film-coated

    Active substance Dosage
    brexpiprazol 4 mg

    ATC: N05A N05AX N05AX16

  • It is used to treat low sodium levels in the blood in adults as a result of syndrome of inappropriate antidiuretic hormone secretion (SIADH), a condition in which the kidneys retain too much water.

    Dosage form: tablets

    Active substance Dosage
    tolvaptan 10 mg

    ATC: C03X C03XA C03XA01

  • It is used to treat low sodium levels in the blood in adults due to a condition called syndrome of inappropriate antidiuretic hormone secretion (SIADH), in which the kidneys retain too much water.

    Dosage form: tablets

    Active substance Dosage
    tolvaptan 30 mg

    ATC: C03X C03XA C03XA01

  • It is used to treat low sodium levels in the blood in adults due to a condition called syndrome of inappropriate antidiuretic hormone secretion (SIADH), in which the kidneys retain too much water.

    Dosage form: tablets

    Active substance Dosage
    tolvaptan 7, 50 mg

    ATC: C03X C03XA C03XA01